Cellular Defects and Altered Gene Expression in PC12 Cells Stably Expressing Mutant Huntingtin
暂无分享,去创建一个
[1] Fumiaki Tanaka,et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy , 1998, Annals of neurology.
[2] S. Rusconi,et al. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. , 1994, Science.
[3] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[4] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[5] M. Yanagida,et al. Molecular Cloning and Cell Cycle-dependent Expression of Mammalian CRM1, a Protein Involved in Nuclear Export of Proteins* , 1997, The Journal of Biological Chemistry.
[6] G. Lewin,et al. Neurotrophins Live or Let Die: Does p75NTR Decide? , 1997, Neuron.
[7] R. Yao,et al. Specific Activation of a c-Jun NH2-terminal Kinase Isoform and Induction of Neurite Outgrowth in PC-12 Cells by Staurosporine* , 1997, The Journal of Biological Chemistry.
[8] A. Hackam,et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates , 1998, Nature Genetics.
[9] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[10] S. Hersch,et al. The Cellular and Subcellular Localization of Huntingtin-Associated Protein 1 (HAP1): Comparison with Huntingtin in Rat and Human , 1998, The Journal of Neuroscience.
[11] S. Snyder,et al. A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.
[12] Michael A. Mancini,et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 , 1998, Nature Genetics.
[13] Nahida Matta,et al. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain , 1995, Neuron.
[14] Harry T Orr,et al. Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.
[15] R. Shigemoto,et al. Localization of a metabotropic glutamate receptor, mGluR7, in axon terminals of presumed nociceptive, primary afferent fibers in the superficial layers of the spinal dorsal horn: an electron microscope study in the rat , 1997, Neuroscience Letters.
[16] R. S. Williams,et al. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease , 1993, Neurology.
[17] C. Dargemont,et al. Evidence for a role of CRM1 in signal-mediated nuclear protein export. , 1997, Science.
[18] M. Chao. Neurotrophin receptors: A window into neuronal differentiation , 1992, Neuron.
[19] R. Tjian,et al. Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.
[20] G. Graveland,et al. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.
[21] B. Birren,et al. Rat metallothionein-1 structural gene and three pseudogenes, one of which contains 5'-regulatory sequences , 1986, Molecular and cellular biology.
[22] R. Bradshaw,et al. Staurosporine Causes Epidermal Growth Factor to Induce Differentiation in PC12 Cells via Receptor Up-regulation (*) , 1995, The Journal of Biological Chemistry.
[23] R. Albin,et al. Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse , 1997, Cell.
[24] Minoru Yoshida,et al. CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.
[25] H. Green,et al. Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. , 1998, Molecular cell.
[26] E. Shooter,et al. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] L. Gollapudi,et al. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine , 1997, Journal of neuroscience research.
[28] L. Greene,et al. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[29] Michael R. Hayden,et al. The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity , 1998, The Journal of cell biology.
[30] K. Moulder,et al. Generation of Neuronal Intranuclear Inclusions by Polyglutamine-GFP: Analysis of Inclusion Clearance and Toxicity as a Function of Polyglutamine Length , 1999, The Journal of Neuroscience.
[31] P. Bhide,et al. Analysis of huntingtin‐associated protein 1 in mouse brain and immortalized striatal neurons , 1999, The Journal of comparative neurology.
[32] S. W. Davies,et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] Kohichi Tanaka. Cloning and expression of a glutamate transporter from mouse brain , 1993, Neuroscience Letters.
[34] Minoru Yoshida,et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal , 1997, Nature.
[35] P. Worley,et al. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. , 1997, Human molecular genetics.
[36] J T Finch,et al. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Tischler,et al. Mimicry and Inhibition of Nerve Growth Factor Effects: Interactions of Staurosporine, Forskolin, and K252a in PC12 Cells and Normal Rat Chromaffin Cells In Vitro , 1990, Journal of neurochemistry.
[38] M. MacDonald,et al. Huntington's disease: translating a CAG repeat into a pathogenic mechanism , 1996, Current Opinion in Neurobiology.
[39] A Dürr,et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. , 1998, Human molecular genetics.
[40] S. Hersch,et al. A Human HAP1 Homologue , 1998, The Journal of Biological Chemistry.
[41] Y. Wang,et al. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. , 1997, Chemistry & biology.
[42] N. Danbolt. The high affinity uptake system for excitatory amino acids in the brain , 1994, Progress in Neurobiology.
[43] A. Roses,et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH , 1996, Nature Medicine.
[44] K. Fischbeck,et al. Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3 , 1997, Neuron.
[45] D. Chuang,et al. Nuclear Translocation of Glyceraldehyde‐3‐Phosphate Dehydrogenase Isoforms During Neuronal Apoptosis , 1999, Journal of neurochemistry.
[46] D. Choi,et al. Staurosporine-Induced Neuronal Apoptosis , 1995, Experimental Neurology.
[47] J. Lancaster,et al. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[48] S. W. Davies,et al. Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length , 1998, Neurobiology of Disease.
[49] S. W. Davies,et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.
[50] Shihua Li,et al. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. , 1998, Human molecular genetics.
[51] D. Housman,et al. The complex pathology of trinucleotide repeats. , 1997, Current opinion in cell biology.
[52] A. Tischler,et al. A protein kinase inhibitor, staurosporine, mimics nerve growth factor induction of neurotensin/neuromedin N gene expression. , 1991, The Journal of biological chemistry.
[53] H. Zoghbi,et al. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1 , 1997, Nature.
[54] S. Hersch,et al. Interaction of Huntingtin-Associated Protein with Dynactin P150Glued , 1998, The Journal of Neuroscience.
[55] S. Tsuji,et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch , 1998, Nature Genetics.
[56] H. Zoghbi,et al. Erratum: Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures , 1998, Nature.
[57] C A Ross,et al. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. , 1998, Human molecular genetics.
[58] H. Paulson,et al. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. , 1999, Human molecular genetics.
[59] H. Lehrach,et al. SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. , 1998, Molecular cell.
[60] H. Lehrach,et al. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. , 1998, Human molecular genetics.
[61] G. Guroff,et al. Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor , 1981, The Journal of cell biology.
[62] M. Karin. Metallothioneins: Proteins in search of function , 1985, Cell.
[63] D. Chuang,et al. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. , 1998, Molecular pharmacology.
[64] R. Burry,et al. Neuronotypic Differentiation Results in Reduced Levels and Altered Distribution of Synaptophysin in PC 12 Cells , 1993, Journal of neurochemistry.
[65] C A Ross,et al. Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.
[66] J. B. Martin,et al. Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.
[67] A. Hackam,et al. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. , 1999, Human molecular genetics.
[68] T. Kao,et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. , 1985, Nucleic acids research.
[69] K. Fischbeck,et al. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. , 1996, Human molecular genetics.
[70] Y. Agid,et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.
[71] H. Zoghbi,et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures , 1997, Nature.
[72] Claire-Anne Gutekunst,et al. Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.
[73] S. Snyder,et al. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[74] R. Tjian,et al. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 , 1989, Cell.
[75] J. Comella,et al. Characterization of the Cell Death Process Induced by Staurosporine in Human Neuroblastoma Cell Lines , 1997, Neuropharmacology.
[76] E. Shooter,et al. Gene transfer and molecular cloning of the rat nerve growth factor receptor , 1987, Nature.